Todd Meyerrose is an accomplished and results-oriented technology leader, currently serving as a Senior Manager, Solutions Architecture at Amazon Web Services (AWS). With extensive experience in cloud computing, enterprise architecture, and software development, Todd excels at guiding organizations through complex digital transformations. He is deeply knowledgeable in designing and implementing scalable, secure, and cost-effective solutions on the AWS platform, covering areas such as serverless computing, containers, IoT, data analytics, and machine learning. Todd is passionate about customer success and innovation, frequently sharing his expertise through technical articles, public speaking engagements, and mentoring.
Todd Meyerrose's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Leads and mentors a high-performing team of Solutions Architects, driving customer adoption and success on the AWS platform by providing expert technical guidance and architectural best practices for a wide range of cloud-based solutions.
Holds the AWS Certified Solutions Architect - Professional certification, validating advanced technical skills and experience in designing distributed applications and systems on the AWS platform.
Authors and co-authors numerous technical articles and blog posts on the official AWS Compute Blog, sharing in-depth knowledge and practical examples on topics like AWS Lambda, containers, serverless architectures, and application modernization.
Frequently presents at industry conferences, AWS Summits, and re:Invent, sharing insights on cloud architecture, serverless patterns, and emerging AWS technologies to a broad technical audience.
Recognized for early adoption and expertise in serverless and container technologies, helping customers architect and optimize modern applications using services like AWS Lambda, Amazon ECS, and Amazon EKS.
Washington University School of Medicine in St. Louis - Year 2002
University of Southern California - Year 1999
University of Kentucky - Year 1992
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Lexent Bio was a biotechnology company focused on developing novel liquid biopsy diagnostics for cancer monitoring and management. Their technology aimed to analyze cell-free DNA (cfDNA) methylation patterns and fragmentation profiles to provide comprehensive insights into tumor biology, enabling earlier detection of recurrence and more precise treatment decisions. The company was acquired by Foundation Medicine, a subsidiary of Roche, in 2020 to integrate Lexent's expertise into Foundation Medicine's portfolio of cancer diagnostics.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.